Symvivo

Share on: 
Website: Symvivo
Business Area(s): 
Description: 

Symvivo has invented and patented a novel protein based mechanism that enables probiotic bacteria to consistently produce and deliver therapeutic plasmid DNA to colonized tissues. Through oral ingestion or intravenous infusion, this platform can be used for many therapeutic applications including: oncology, cardiovascular injuries, infectious diseases, vaccines, and genetic diseases.

Location(s): 
Burnaby BC
Canada